Swift Biosciences Inc:医療機器:M&Aディール及び事業提携情報

【英語タイトル】Swift Biosciences Inc - Medical Equipment - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C10405)・商品コード:DATA904C10405
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:35
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA library kit, comprehensive TP53 panel, 56G oncology panel, EGFR pathway panel and sample ID panel, among others. It develops technologies to examine disease-related genes, improve next generation sequencing sample preparation for illumina and ion torrent platforms, and accelerate sample preparation for DNA sequencing and deliver more usable data from next gen sequencing instruments. The company’s products finds application in circulating cell free DNA and tumor cells, amplicon sequencing, bisulfite sequencing, molecular identifiers, hybridization capture sequencing, whole genome sequencing, metagenomics, and others. Swift Biosciences is headquartered in Ann Arbor, Michigan, the US.

Swift Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Swift Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Swift Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Swift Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Swift Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Swift Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Swift Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Swift Biosciences Raises USD12.2 Million in Venture Financing 10
Swift Biosciences Raises USD3.3 Million in Venture Financing 11
Swift Biosciences Raises USD1.5 Million in Venture Financing 12
Swift Biosciences Raises US$7 Million In Series B Financing 13
Swift Biosciences Raises US$0.8 Million In Series A-1 Financing Round 14
Swift Biosciences Raises US$0.5 Million In Venture Financing 15
Partnerships 16
Swift Biosciences Enters Into Licensing Agreement With Vela Diagnostics For Cancer Detection Technology 16
Swift Biosciences and Genomenon Enter into Partnership 17
Silicon Biosystems Menarini and Swift Biosciences Enter into Partnership 18
Sophia Genetics Enters into Agreement with Swift Biosciences 19
Swift Biosciences Partners with SeraCare Life Sciences 20
Swift Biosciences Inc – Key Competitors 21
Swift Biosciences Inc – Key Employees 22
Swift Biosciences Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Strategy And Business Planning 24
Oct 05, 2017: Swift Biosciences Growth Sparks Expansion into New Headquarters & First West Coast Office 24
Corporate Communications 25
May 23, 2018: Swift Biosciences Builds on Momentum, Accelerates Growth with Addition of Nathan Wood as New CEO 25
Jun 29, 2017: Swift Biosciences adds two new Directors to Board 26
Feb 09, 2017: Swift Biosciences Expands Team, Hires Vice President of Marketing 27
Product News 28
Apr 06, 2018: Swift Biosciences Launches Unique Dual Indexing Kits to improve Multiplexed Next Generation Sequencing 28
Oct 12, 2017: Swift Launches Accel-Amplicon Custom NGS Panels, Accelerating Variant Discovery In Challenging Biological Samples 29
Aug 10, 2017: Swift Announces the Highest Throughput Single-Cell Methyl-Seq Library Preparation Method 30
Aug 03, 2017: Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run 31
Mar 22, 2017: Swift Biosciences Launches New Assay for Faster, More Efficient Routine Screening of the CFTR Gene 32
Feb 14, 2017: Swift Biosciences Launches Novel Long-Insert Library Kit to Improve Data Quality on PacBio Sequencing Platforms 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Swift Biosciences Inc, Medical Equipment, Key Facts 2
Swift Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Swift Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Swift Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Swift Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Swift Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Swift Biosciences Raises USD12.2 Million in Venture Financing 10
Swift Biosciences Raises USD3.3 Million in Venture Financing 11
Swift Biosciences Raises USD1.5 Million in Venture Financing 12
Swift Biosciences Raises US$7 Million In Series B Financing 13
Swift Biosciences Raises US$0.8 Million In Series A-1 Financing Round 14
Swift Biosciences Raises US$0.5 Million In Venture Financing 15
Swift Biosciences Enters Into Licensing Agreement With Vela Diagnostics For Cancer Detection Technology 16
Swift Biosciences and Genomenon Enter into Partnership 17
Silicon Biosystems Menarini and Swift Biosciences Enter into Partnership 18
Sophia Genetics Enters into Agreement with Swift Biosciences 19
Swift Biosciences Partners with SeraCare Life Sciences 20
Swift Biosciences Inc, Key Competitors 21
Swift Biosciences Inc, Key Employees 22

List of Figures
Swift Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Swift Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Swift Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Swift Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Swift Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★調査レポート[Swift Biosciences Inc:医療機器:M&Aディール及び事業提携情報] (コード:DATA904C10405)販売に関する免責事項を必ずご確認ください。
★調査レポート[Swift Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆